Debut Plus

₹75.01

▼ -3.09 -3.96%

10 Sept 2026

BSE Listed

ESM · ESM 1
What does ESM · ESM 1 mean?
BSE · Enhanced Surveillance Measure (ESM 1)ESM is the micro/small-cap ramp brake: it fires when a sub-₹1000cr stock's price variation is extreme versus its peer universe, or it's loss-making with a stretched valuation. Practical meaning: intraday speculation is shut off (Trade-for-Trade — every purchase must be taken to delivery), margins go to 100%, and at Stage II price discovery moves to periodic call auctions inside a 2% band.Criteria: Micro / small-cap companies (main-board market-cap below ₹500 cr) shortlisted on objective price parameters — high-low price variation, close-to-close price variation and standard deviation. Stage I = 100% margin + a ≤5% price band + Trade-for-Trade; Stage II = a 2% price band + periodic call auction.Exchange notice · 2026-06-17

Novelix Pharmaceuticals Limited (536565)

Volume: 1,214Avg Vol 1W: 2,477Avg Vol 1M: 3,91052W Range:₹38₹92
BSE www.trimurthidrugs.com AI Report
Key Ratios
Checked just now
Market Cap₹109 Cr
Current Price₹75.01
Previous Close₹78.1
High / Low (52w)₹92 / ₹38
Volume1,214
Avg Vol (1W)2,477
Avg Vol (1M)3,910
Stock P/E—
Book Value₹12.51
Dividend Yield0%
ROE-30.18%
ROA-30.18%
Revenue (TTM)—
Revenue Growth—
Profit Margin-49.32%
Total Debt—
Shares Outstanding1 Cr
Face Value—
EPS (TTM)₹0
P/B6
Debt / Equity0.01
50 DMA₹74.08
200 DMA₹63.49
Day change-3.96%
SurveillanceESM · ESM 1
Price Chart
₹75.01▲ 78.60% · 1Y
₹89₹2994K
2025-09-10
2026-09-10

20-day avg volume: 4K shares

Pros
  • Company is almost debt-free.
  • Revenue grew 47% YoY.
  • Net profit is growing year over year.
Quarterly Results
MetricDec 2020Mar 2021Jun 2021Sept 2021Dec 2021Mar 2022Jun 2022Sept 2022
Revenue₹2 Cr₹3 Cr₹4 Cr₹2 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr
EBITDA₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Net Profit₹0 Cr₹-3 Cr₹0 Cr₹0 Cr₹-1 Cr₹-1 Cr₹0 Cr₹0 Cr
EPS————————
Profit & Loss (Annual)
MetricSept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Revenue₹4 Cr₹5 Cr₹21 Cr₹22 Cr₹36 Cr₹48 Cr₹25 Cr₹37 Cr
EBITDA₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr
Net Profit₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr
EPS————————
Balance Sheet
MetricMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022
Total Assets₹13 Cr₹13 Cr₹14 Cr₹14 Cr₹13 Cr₹14 Cr₹10 Cr₹9 Cr
Total Liabilities₹1 Cr₹1 Cr₹2 Cr₹2 Cr₹2 Cr₹3 Cr₹2 Cr₹1 Cr
Equity₹12 Cr₹12 Cr₹12 Cr₹12 Cr₹11 Cr₹11 Cr₹7 Cr₹8 Cr
Total Debt————————
Cash Flow
MetricMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022
Operating₹-1 Cr₹2 Cr₹-2 Cr₹0 Cr₹-1 Cr₹1 Cr₹2 Cr₹1 Cr
Investing₹0 Cr₹-1 Cr₹0 Cr₹-1 Cr₹0 Cr₹0 Cr₹0 Cr₹-1 Cr
Financing₹0 Cr₹0 Cr₹1 Cr₹0 Cr₹0 Cr₹0 Cr₹-1 Cr₹0 Cr
Free Cash Flow₹-1 Cr₹2 Cr₹-2 Cr₹1 Cr₹-1 Cr₹1 Cr₹2 Cr₹1 Cr
Shareholding
Promoter 54.29% Institutions 0% Public 45.71%
Efficiency & Working Capital
ROCE-32.5%
Interest Coverage-33
Dividend Payout—
Debtor Days52 d
Inventory Days42 d
Payable Days37 d
Cash Conversion Cycle57 d
Working Capital Days94 d
Shareholding Details

As of 2026-07-31

Promoter54.3%
FII0%
DII0%
Institutions0%
Public45.7%
Promoter Pledge0%
No. of Shareholders3,127
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodDec 2024Mar 2025Jun 2025Aug 2025Sept 2025Nov 2025Dec 2025Jan 2026Feb 2026Mar 2026Jun 2026Jul 2026
Promoters66.6%66.6%52.7%53.3%54.8%54.8%52%50.8%46.5%49.4%50.6%54.3%
FIIs0%0%0%0%0%0%0%0%0%0%0%0%
DIIs0%0%0%0%0%0%0%0%0%0%0%0%
Public33.4%33.4%47.3%46.7%45.2%45.2%48%49.2%53.5%50.6%49.4%45.7%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders2,5022,4842,4082,7542,7702,7702,9942,9973,0292,9753,1183,127
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503————
Major Shareholders (>1%)
NameCategoryStakeShares
Srinidhi Fine-chemicals LlpShareholding of Promoter and Promoter Group35.1%1.00 Cr
Vupparapalli Chandrasekhar ReddyShareholding of Promoter and Promoter Group10.2%29,05,733
Mallela Venkatramna ReddyPublic Shareholding6.4%18,30,000
Narhari BelideShareholding of Promoter and Promoter Group4.2%12,00,000
Sesha Sai Nikhil ChintalapatiPublic Shareholding3.4%9,68,000
Srinivasrao Swetha KanakapurPublic Shareholding3.1%8,67,000
Vupparapalli PavaniShareholding of Promoter and Promoter Group2.6%7,25,000
Panchagnula Venkata Lakshmi Narayana Sankara Vara PrasadPublic Shareholding2.2%6,25,000
Palakurthi RakeshPublic Shareholding2%5,74,125
Gattu Gnana PrakashShareholding of Promoter and Promoter Group1.4%4,00,000
Arati GattuShareholding of Promoter and Promoter Group0.4%1,00,000
Neha GattuShareholding of Promoter and Promoter Group0.4%1,00,000
Shyam Agarwal (huf)Shareholding of Promoter and Promoter Group0.1%25,000
Board of Directors
NameDesignationYear
VENKATESHWARLU PULLURUE D & Wholetime Director2025
JANARDHAN DAS KABRAIndependent Non Exe. Director2025
Jivamohan Divakar ValluriNon-Exec & Non-Independent Dir2025
Monam KapoorIndependent Non Exe. Director2025
Lakshman SamalaIndependent Non Exe. Director2025
GNANA PRAKASH GATTUWhole Time Director2025
Mayuri BaidyaIndependent Non Exe. Director2025
Nishita KalantriCompany Sec. & Compli. Officer2025
Sridevi BelideDirector2025
Segments — Product
SegmentRevenueShare
Pharma Business₹0 Cr3.2%
Financial Activity₹0 Cr4.5%
Investment Activity₹0 Cr1.5%
Trading in Shares₹4 Cr90.8%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹10201010
Corporate Actions
TypeDateValueRemark
forthcoming2026-08-13Board Meetings—
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
2025000000
2025000000
2025000000
Insider / Designated-Person Trades

9 recent disclosure(s)

Neha GattuAcquisition · 1,00,000
VUPPARAPALLI CHANDRASEKHARAcquisition · 7,75,000
Narhari BelideAcquisition · 4,00,000
SRINIDHI FINE CHEMICALS LLPAcquisition · 21,00,000
Arati GattuAcquisition · 1,00,000
Gattu Gnana PrakashAcquisition · 50,000
Substantial Acquisitions (SAST)

7 disclosure(s)

Conv. of Warrants09/07/2026 · 7,75,000
Conv. of Warrants09/07/2026 · 21,00,000
Conv. of Warrants09/07/2026 · 1,00,000
Pref. Allotment12/02/2026 · 3,25,000
Pref. Allotment12/02/2026 · 3,25,000
Pref. Allotment12/02/2026 · 3,25,000
Company Information
Incorporated1994
AuditorCVS Bala Chandra Rao & Co
Investor Email[email protected]
🌐 www.trimurthidrugs.com ↗

📍 4-4-231/1/2/ABC Inderbagh, Sultan Bazar, Hyderabad, Telangana, 500095

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Money Masters Leasing & Finance Ltd.Alacrity Securities Ltd.GCM Commodity & Derivatives Ltd.Julien Agro Infratech LimitedJK Agri Genetics Ltd.Future Lifestyle FashionsPVV Infra LimitedVCU Data Management Ltd.IND Renewable Energy Ltd.SRG Fingrow Finance LimitedAmrapali Capital and Finance Services Ltd.Stellar Capital Services Ltd.All “53” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search